Daiichi Sankyo Company Limited (D4S MU) stock market data APIs
€20.6964
0(0%)
as of September 18, 2025
Try our APIs with
free plan!
Daiichi Sankyo Company Limited Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for D4S.MU.
Prev. Close
20.6964
Open
20.6964
High
20.6964
Low
20.6964
52 wk Range
18.405-30.988
Market Cap
38 045 M
Dividends (Yield)
0.5932
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Daiichi Sankyo Company Limited data using free add-ons & libraries
Get Daiichi Sankyo Company Limited Fundamental Data
Daiichi Sankyo Company Limited Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Daiichi Sankyo Company Limited News
New
Immuto Scientific Announces $8M Seed 2 Financing and Daiichi Sankyo Collaboration to Uncover a New Class of Therapeutic Targets with Structural Surfaceomics
Immuto Scientific unveils collaboration with Daiichi Sankyo to identify cancer‑specific cell‑surface targets MADISON, Wis. & CAMBRIDGE, Mass., September 18, 2025--(BUSINESS WIRE)--Immuto Scientif...
Risk Assets Expected to Benefit From Fed Rate Cut
The Fed’s rate cut was likely to boost short-term sentiment for risk assets, with the stock market expected to benefit, according to Moneyfarm. Continue Reading View Comments
Nikkei Up 0.3%, Led by Electronics, Pharma Stocks
Japanese stocks were higher as the yen weakens against the dollar following the Fed’s widely expected rate cut overnight. Continue Reading View Comments
MRK, Daiichi's ADC Drug Gets FDA Breakthrough Tag for Ovarian Cancer
Merck (MRK) and its Japanese partner Daiichi Sankyo announced that the FDA has granted Breakthrough Therapy Designation ("BTD") to their investigational pipeline candidate, raludotatug deruxtecan (R-...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
